Omega Healthcare Investors, Inc. files regulatory documents that record its healthcare REIT results, governance and capital-structure activity. Form 8-K reports include quarterly and annual financial results, AFFO and FAD metrics, investment activity and Regulation FD exhibits tied to earnings releases.
The filing record also documents proxy matters, executive compensation disclosures, employment-agreement amendments, at-the-market common stock programs, senior unsecured credit facilities, note redemptions and the company’s NYSE-listed common stock. These disclosures frame Omega’s public reporting around long-term healthcare real estate, operator relationships, leverage and shareholder governance.
Omega Healthcare Investors director Stephen D. Plavin reported equity-based compensation and a derivative conversion. On June 5, 2026, he received a grant of 3,814 Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership at a price of $0.00 per unit.
All 4,424 of his previously granted PIUs from June 6, 2025 vested and converted into 4,424 OP Units on the same date. Following the conversion, he directly holds 23,215 OP Units. Each OP Unit can be redeemed for cash equal to the fair market value of one share of Omega Healthcare common stock, or, at the company’s election, one share of common stock. The new 2026 PIUs will vest in full on the date of the company’s 2027 Annual Meeting of Shareholders, subject to continued service.
Omega Healthcare Investors director Kevin J. Jacobs received an equity grant of 6,125 shares of Common Stock as director compensation. The award was granted on June 5, 2026 under a Restricted Stock Grant Award Agreement at a reference price of $43.67 per share.
According to the terms, the restricted shares will vest on the date of the company’s 2027 Annual Meeting of Shareholders, approximately one year from the grant date, and will convert to common stock on a one-for-one basis. After this grant, Jacobs directly holds 46,935 shares of Omega Healthcare Investors common stock.
Omega Healthcare Investors director Barbara B. Hill reported equity-based compensation and conversions. She received a grant of 6,102 Profits Interest Units (PIUs) in the company’s operating partnership as annual stock-based compensation. Separately, 7,079 previously granted PIUs fully vested and converted into OP Units, which are partnership interests redeemable for cash equal to the value of one common share or, at the company’s election, one share of common stock. Following these transactions, Hill directly holds 49,073 OP Units in the operating partnership.
Omega Healthcare Investors director Lisa Egbuonu-Davis received a grant of 3,778 shares of common stock as director compensation on June 5, 2026. The award was made via a Restricted Stock Grant Award Agreement at an indicated value of $43.67 per share.
The restricted shares will vest on the date of the company’s 2027 Annual Meeting of Shareholders, approximately one year from the grant date, and will convert to common stock on a one-for-one basis. Following this compensation grant, Egbuonu-Davis directly holds 22,432 shares of Omega Healthcare Investors common stock.
OMEGA HEALTHCARE INVESTORS INC director Anand Kapila K received an equity award in the form of deferred stock units. On the reported date, he was granted 6,205 Deferred Stock Units at no cash cost as an annual restricted stock grant elected to be taken in this form.
Each unit converts into one share of common stock, and related dividends can also be credited as additional units if elected. The units are restricted from transfer or sale until Omega's 2027 Annual Meeting of Shareholders, defined as the vesting date, and will convert into common shares upon separation from service, death, disability, or other specified plan events. Following this grant, he holds 44,992 Deferred Stock Units directly.
OMEGA HEALTHCARE INVESTORS INC director Craig R. Callen reported equity-based compensation and related conversions, with only acquisition-type transactions and no share sales. He received a grant of 9,708 Profits Interest Units (PIUs) on June 5, 2026, representing a contingent right to receive an equal number of OP Units upon vesting and satisfaction of tax-driven economic requirements. On the same date, 11,263 previously granted PIUs vested and converted into 11,263 OP Units. A related transaction shows 11,263 OP Units exercised into common stock equivalents, leaving 74,310 OP Units held directly. The 2026 PIU grant is described as his annual stock grant and will fully vest on the date of the company’s 2027 Annual Meeting of Shareholders, subject to continued service.
Omega Healthcare Investors, Inc. held its 2026 Annual Meeting of Stockholders, where 255,926,290 shares were represented, about 85.93% of shares outstanding as of the record date. Stockholders elected all eight director nominees, ratified Ernst & Young LLP as independent auditor for the year ending December 31, 2026, and approved Omega’s executive compensation on an advisory basis.
The company also updated information on large stockholders. As of April 8, 2026, filings show Vanguard Portfolio Management beneficially owning 27,160,324 shares (9.1% of the class), Vanguard Capital Management 15,689,615 shares (5.3%), and BlackRock, Inc. 31,867,200 shares (10.7%).
PICKETT C TAYLOR reported open-market sale transactions in this Form 4 filing.
Omega Healthcare Investors CEO C. Taylor Pickett reported a redemption of 112,500 OP Units for cash. According to the filing, each OP Unit of OHI Healthcare Properties Limited Partnership was redeemed at $47.94, equal to the 10-day average closing price of the company’s common stock before the redemption notice.
Each OP Unit is redeemable, at the holder’s election, for cash equal to the fair market value of one share of common stock or, at the company’s election, one share of common stock and has no expiration date. After these transactions, Pickett also has OP Units representing an underlying 1,225,003 shares of common stock held directly.
Omega Healthcare Investors is implementing a planned leadership transition, with longtime CEO Taylor Pickett retiring effective October 1, 2026 and stepping down from the Board. President Matthew Gourmand will become CEO and is expected to join the Board on that date. CFO Bob Stephenson will retire effective August 1, 2026, with Chief Accounting Officer Neal Ballew promoted to CFO and Lucas Golem becoming Chief Accounting Officer on the same date.
Pickett and Stephenson each signed transition and consulting agreements. Pickett will receive his 2026 annual incentive un‑prorated, equity vesting through December 31, 2029, company-paid health premiums for up to 18 months, transfer of a supplemental life policy, and a consulting role through at least October 1, 2027 at $20,000 per month. Stephenson will receive benefits consistent with a termination without cause under his employment agreement, plus un‑prorated 2026 incentive, equity vesting through December 31, 2029, transfer of a supplemental life policy and a consulting role through at least August 1, 2027 at $12,000 per month. The company highlights that under Pickett’s 25-year tenure, total shareholder return exceeded 10,000%, the portfolio grew from 258 to 1,124 assets, and market capitalization rose from about $60 million to over $15 billion.
Omega Healthcare Investors Inc ownership filing shows Vanguard Capital Management reports beneficial ownership of 15,689,615 shares of Common Stock, representing 5.30% of the class as reported. The filing lists sole voting power: 2,455,494 and sole dispositive power: 15,689,615; signature dated 04/30/2026.